glp-1 microbiome Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy GLP‐1 agonists and the gut

doi:10.1186/1471-2407-6-292 41

Limitations of the Research Despite promising animal studies, key limitations remain: Human studies are sparse: Most research is conducted in rodents with few clinical trials

Cilostazol inhibits platelet aggregation and promotes dilation of arteries, and is mainly used to treat peripheral artery disease

As with any supplement that influences appetite or metabolism, consulting a qualified healthcare professional is recommended particularly for individuals who are pregnant, nursing, or managing chronic conditions

The use of these products shows significant improvement in skin complexion